EconPapers    
Economics at your fingertips  
 

μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence

Laura M. Bohn, Raul R. Gainetdinov, Fang-Tsyr Lin, Robert J. Lefkowitz and Marc G. Caron ()
Additional contact information
Laura M. Bohn: Howard Hughes Medical Institute Laboratories, Duke University Medical Center
Raul R. Gainetdinov: Howard Hughes Medical Institute Laboratories, Duke University Medical Center
Fang-Tsyr Lin: Howard Hughes Medical Institute Laboratories, Duke University Medical Center
Robert J. Lefkowitz: Howard Hughes Medical Institute Laboratories, Duke University Medical Center
Marc G. Caron: Howard Hughes Medical Institute Laboratories, Duke University Medical Center

Nature, 2000, vol. 408, issue 6813, 720-723

Abstract: Abstract Morphine is a powerful pain reliever, but also a potent inducer of tolerance and dependence. The development of opiate tolerance occurs on continued use of the drug such that the amount of drug required to elicit pain relief must be increased to compensate for diminished responsiveness1,2,3. In many systems, decreased responsiveness to agonists has been correlated with the desensitization of G-protein-coupled receptors. In vitro evidence indicates that this process involves phosphorylation of G-protein-coupled receptors and subsequent binding of regulatory proteins called β-arrestins4,5. Using a knockout mouse lacking β-arrestin-2 (βarr2-/-), we have assessed the contribution of desensitization of the μ-opioid receptor to the development of morphine antinociceptive tolerance and the subsequent onset of physical dependence. Here we show that in mice lacking β-arrestin-2, desensitization of the μ-opioid receptor does not occur after chronic morphine treatment, and that these animals fail to develop antinociceptive tolerance. However, the deletion of β-arrestin-2 does not prevent the chronic morphine-induced upregulation of adenylyl cyclase activity, a cellular marker of dependence, and the mutant mice still become physically dependent on the drug.

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35047086 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:408:y:2000:i:6813:d:10.1038_35047086

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35047086

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:408:y:2000:i:6813:d:10.1038_35047086